

UMass Chan licenses monoclonal antibody for seasonal prevention of Lyme disease to Tonix Pharmaceuticals
UMass Chan Medical School has licensed worldwide rights to a long-lasting human monoclonal antibody that prevents Lyme disease to New Jersey-based Tonix Pharmaceuticals Holding Corp.
Category: Graduate School of Biomedical Sciences,School of Medicine,Medicine,Clinician,Faculty,Research,Terence Flotte,Latest News,BRIDGE,Top Stories
Read more